In a North American study of 267 pediatric ADS patients, 71% exhibited a monophasic course; among these, 61% were MOG-Ab-positive at onset, and relapses were rare in children who did not satisfy diagnostic criteria for MS or AQP4-NMOSD [6,7]. This evidence concerns the gene AQP4 and myeloid sarcoma.